Sackler Family Agrees to $6.5 Billion Opioid Settlement

The Sackler family, owners of Purdue Pharma, have agreed to increase their financial contribution to a new bankruptcy settlement for opioid lawsuits to approximately $6.5 billion, up from a previous agreement of $6 billion. This development was reported by the Wall Street Journal.

Sackler Family Agrees to $6.5 Billion Opioid Settlement

The Sackler family, known as the proprietors behind Purdue Pharma, has agreed to enhance their financial contribution in a fresh bankruptcy settlement aimed at resolving opioid lawsuits.

According to reports by the Wall Street Journal, the tentative increase in the family's contribution is from $6 billion to roughly $6.5 billion.

This agreement signifies a critical step forward in addressing the multiple opioid-related claims that Purdue Pharma faces.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.